Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Abciximab reduces mortality in diabetics following percutaneous coronary intervention.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Abciximab reduces mortality in diabetics following percutaneous coronary intervention.
Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000 Mar 15; 35(4):922-8.
View in:
PubMed
subject areas
Adult
Aged
Angina, Unstable
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal
Diabetic Angiopathies
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Immunoglobulin Fab Fragments
Male
Middle Aged
Myocardial Infarction
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Randomized Controlled Trials as Topic
Recurrence
Risk Factors
Stents
Survival Rate
authors with profiles
Deepak L. Bhatt, M.D.